Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 35
1.
Nutr Metab Cardiovasc Dis ; 29(1): 51-61, 2019 01.
Article En | MEDLINE | ID: mdl-30454883

BACKGROUND AND AIMS: Blood lipid fractions serve as objective biomarkers of dietary fat intake. It is unclear which fatty acid pool most accurately reflects the dietary intakes of different n-3 PUFAs. We aimed to investigate the effect of fish and camelina sativa oil (CSO) intakes on fatty acid composition of erythrocyte membranes (EM), plasma phospholipids (PL), cholesteryl esters (CE) and triglycerides (TG). We also aimed to identify the most appropriate blood lipid fraction for assessing n-3 PUFA intake. METHODS AND RESULTS: Altogether 79 volunteers with impaired glucose metabolism were randomly assigned either to CSO, fatty fish, lean fish or control groups for 12 weeks. Fatty acid compositions of lipid pools were measured by gas chromatography. The proportion of alpha-linolenic acid (ALA) increased in all lipid pools in the CSO group (false discovery rate (FDR) p < 0.001 for all). Similarly, the proportions of EPA and DHA increased in all lipid fractions in the fatty fish group (FDR p < 0.001 for EM, PL and CE; FDR p = 0.005 for TG; FDR p < 0.001 for EM, PL, CE; FDR p < 0.007 for TG, respectively). Changes in the dietary intakes of ALA, EPA and DHA correlated with the changes in their proportions in all lipid pools (r = 0.3-0.5, p < 0.05). CONCLUSION: There is no difference in the ability of blood lipid fractions in reflecting the dietary intake of different n-3 PUFAs over a time period of 12 weeks in subjects with high baseline omega-3 index. This trial was registered in Clinicaltrials.gov (NCT01768429).


Blood Glucose/metabolism , Brassicaceae , Dietary Supplements , Erythrocyte Membrane/metabolism , Fatty Acids, Omega-3/administration & dosage , Glucose Intolerance/therapy , Plant Oils/administration & dosage , Seafood , Biomarkers/blood , Fatty Acids, Omega-3/blood , Finland , Glucose Intolerance/blood , Glucose Intolerance/diagnosis , Humans , Plant Oils/metabolism , Time Factors , Treatment Outcome
2.
Scand J Med Sci Sports ; 28(7): 1808-1817, 2018 Jul.
Article En | MEDLINE | ID: mdl-29474750

Impaired expression of heat shock proteins (HSPs) and increased oxidative stress may contribute to the pathophysiology of diabetes by disrupted tissue protection. Acute exercise induces oxidative stress, whereas exercise training up-regulates endogenous antioxidant defenses and HSP expression. Although diabetic nephropathy is a major contributor to diabetic morbidity, information regarding the effect of HSPs on kidney protection is limited. This study evaluated the effects of eight-week exercise training on kidney HSP expression and markers of oxidative stress at rest and after acute exercise in rats with or without streptozotocin-induced diabetes. Induction of diabetes increased DNA-binding activity of heat shock factor-1, but decreased the expression of HSP72, HSP60, and HSP90. The inflammatory markers IL-6 and TNF-alpha were increased in the kidney tissue of diabetic animals. Both exercise training and acute exercise increased HSP72 and HSP90 protein levels only in non-diabetic rats. On the other hand, exercise training appeared to reverse the diabetes-induced histological changes together with decreased expression of TGF-beta as a key inducer of glomerulosclerosis, and decreased levels of IL-6 and TNF-alpha. Notably, HSP72 and TGF-beta were negatively correlated. In conclusion, impaired HSP defense seems to contribute to kidney injury vulnerability in diabetes and exercise training does not up-regulate kidney HSP expression despite the improvements in histopathological and inflammatory markers.


Diabetes Mellitus, Experimental/physiopathology , Heat-Shock Response , Kidney/physiopathology , Physical Conditioning, Animal , Animals , Chaperonin 60/metabolism , HSP72 Heat-Shock Proteins/metabolism , HSP90 Heat-Shock Proteins/metabolism , Interleukin-6/metabolism , Male , Mitochondrial Proteins/metabolism , Oxidative Stress , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism
3.
Nutr Metab Cardiovasc Dis ; 26(9): 833-41, 2016 09.
Article En | MEDLINE | ID: mdl-27397511

BACKGROUND AND AIMS: There are no studies on the relationships of dietary quality indices to the clustering of cardiometabolic risk factors in children. We therefore investigated the associations of four dietary quality indices with cardiometabolic risk score and cardiometabolic risk factors in Finnish children. METHODS AND RESULTS: Subjects were a population sample of 204 boys and 198 girls aged 6-8 years. We assessed diet by 4-day food records and calculated Dietary Approaches to Stop Hypertension (DASH) Score, Baltic Sea Diet Score (BSDS), Mediterranean Diet Score (MDS), and Finnish Children Healthy Eating Index (FCHEI). We calculated the age- and sex-adjusted cardiometabolic risk score summing up Z-scores for waist circumference, mean of systolic and diastolic blood pressure and concentrations of fasting serum insulin and fasting plasma glucose, triglycerides and HDL cholesterol, the last multiplying by -1. Higher FCHEI was associated with lower cardiometabolic risk score among boys (standardised regression coefficient ß = -0.14, P = 0.044) adjusted for age, physical activity, electronic media time and household income. Higher DASH Score was related to a lower serum insulin in boys (ß = -0.15, P = 0.028). Higher DASH Score (ß = -0.16, P = 0.023) and FCHEI (ß = -0.17, P = 0.014) were related to lower triglyceride concentration in boys. Higher FCHEI was associated with lower triglyceride concentration in girls (ß = -0.16, P = 0.033). Higher DASH Score (ß = -0.19, P = 0.011) and BSDS (ß = -0.23, P = 0.001) were associated with lower plasma HDL cholesterol concentration in girls. CONCLUSION: Higher FCHEI was associated with lower cardiometabolic risk among boys, whereas DASH Score, BSDS or MDS were not associated with cardiometabolic risk in children.


Diet, Healthy , Diet/adverse effects , Feeding Behavior , Metabolic Syndrome/epidemiology , Nutritive Value , Age Factors , Biomarkers/blood , Blood Glucose/analysis , Blood Pressure , Child , Diet, Mediterranean , Female , Finland/epidemiology , Humans , Insulin/blood , Life Style , Lipids/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diagnosis , Metabolic Syndrome/physiopathology , Nutritional Status , Risk Assessment , Risk Factors , Sex Factors , Waist Circumference
4.
Eur J Nutr ; 53(6): 1431-9, 2014 Sep.
Article En | MEDLINE | ID: mdl-24374820

PURPOSE: Previous evidence for the associations of eating frequency and food consumption with clustering of metabolic risk factors among children is limited. We therefore investigated association of the daily number of main meals and snacks and food consumption with a metabolic risk score and individual metabolic risk factors in primary school children. METHODS: The subjects were a population sample of Finnish girls and boys 6-8 years of age. Dietary factors were measured by a four-day food record. Metabolic risk score was calculated summing up the Z-scores of waist circumference, systolic and diastolic blood pressure, and concentrations of fasting serum insulin and fasting plasma glucose, triglycerides and high-density lipoprotein cholesterol, the latest multiplying by -1. RESULTS: Skipping main meals (standardized regression coefficient ß = -0.18, P < 0.001), a higher consumption of non-root vegetables (ß = 0.18, P < 0.01), low-fat vegetable-oil-based margarine (ß = 0.13, P < 0.01) and sugar-sweetened beverages (ß = 0.11, P < 0.05) and a lower consumption of vegetable oils (ß = -0.10, P < 0.05) were associated with a higher metabolic risk score after adjustment for age, sex, total physical activity, electronic media time, energy intake and other dietary factors. The consumption of red meat was directly related to the metabolic risk score, but the association was not statistically significant after adjustment for energy intake. CONCLUSIONS: Eating main meals regularly, decreasing the consumption of sugar-sweetened beverages and low-fat margarine and increasing the consumption of vegetable oils should be emphasized to reduce metabolic risk among children.


Feeding Behavior , Metabolic Syndrome/prevention & control , Nutrition Assessment , Beverages , Blood Glucose/metabolism , Blood Pressure/physiology , Body Composition , Child , Cholesterol, LDL/blood , Cross-Sectional Studies , Dietary Carbohydrates/analysis , Energy Intake , Fasting , Female , Finland , Humans , Insulin/blood , Linear Models , Lipoproteins, HDL/blood , Male , Motor Activity , Risk Factors , Triglycerides/blood , Vegetables , Waist Circumference , White People
5.
J Intern Med ; 270(6): 589-96, 2011 Dec.
Article En | MEDLINE | ID: mdl-21801244

BACKGROUND: A slow heart rate recovery (HRR) after an exercise test is associated with an increased risk of all-cause mortality in asymptomatic individuals, but the data regarding additional prognostic information provided by HRR beyond other exercise test variables are inconsistent. We investigated the prognostic significance of HRR for premature death, particularly in relation to other exercise test variables. METHODS: The study subjects were a representative population-based sample of 1102 men (42-61 years of age) without cardiovascular disease, cancer or diabetes. HRR was defined as the difference between maximal HR and HR 2 min after a maximal symptom-limited exercise test using a cycle ergometer. The association between HRR and premature mortality was examined with Cox regression models. RESULTS: During an average follow-up of 18 years, 238 deaths occurred. HRR was an independent predictor of death [for a decrease of 12 beats min(-1) , relative risk (RR) 1.16, 95% CI 1.02-1.33, P = 0.02] after adjustment for age and established risk factors. When added in a Cox model with chronotropic response (decrease of 12 beats min(-1) , RR 1.09, 95% CI 0.93-1.27, P = 0.26) or cardiorespiratory fitness (decrease of 12 beats min(-1) , RR 1.12, 95% CI 0.98-1.30, P = 0.08), the association between a slow HRR and an increased risk of death was clearly weaker. CONCLUSION: A slow 2-min HRR after a cycle ergometer exercise test was an independent predictor of death in healthy middle-aged men after accounting for demographic and clinical characteristics. However, it was no longer predictive after accounting for chronotropic response and exercise capacity.


Cardiovascular Diseases/mortality , Exercise Test/methods , Exercise Tolerance/physiology , Exercise/physiology , Heart Rate/physiology , Mortality, Premature , Adult , Cause of Death , Cohort Studies , Exercise Test/standards , Finland , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Proportional Hazards Models
6.
Eur J Clin Nutr ; 65(10): 1148-55, 2011 Oct.
Article En | MEDLINE | ID: mdl-21587284

BACKGROUND/OBJECTIVES: To predict the health economic consequences of modest reductions in the daily intake of salt (-1.0 g per day) and replacement of saturated fat (SFA, -1.0 energy percent (E%)) with polyunsaturated fat (PUFA, +1.0 E%) in the Finnish population aged 30-74 years. SUBJECTS/METHODS: A Markov model with dynamic population structure was constructed to present the natural history of cardiovascular diseases (CVDs) based on the most current information about the age- and sex-specific cardiovascular risk factors, dietary habits and nutrient intake. To predict the undiscounted future health economic consequences of the reduction of dietary salt and SFA, the model results were extrapolated for the years 2010-2030 by replacing the baseline population in the year 2007 with the extrapolated populations from the official Finnish statistics. Finnish costs (€2009, societal perspective) and EQ-5D utilities were obtained from published references. RESULTS: During the next 20 years, a population-wide intervention directed at salt intake and dietary fat quality could potentially lead to 8000-13,000 prevented CVD cases among the Finnish adults compared the situation in year 2007. In addition, the reduced incidence of CVDs could gain 26,000-45,000 quality-adjusted life years and save €150-225 million over the same time period. CONCLUSION: A modest reduction of salt and replacement of SFA with PUFA in food products can significantly reduce the burden of CVD in the adult Finnish population. This impact may be even larger in the near future due to the ageing of Finnish population.


Diet , Dietary Fats, Unsaturated/administration & dosage , Fatty Acids/administration & dosage , Feeding Behavior , Health Promotion/economics , Sodium Chloride, Dietary/administration & dosage , Adult , Aged , Cardiovascular Diseases/prevention & control , Choice Behavior , Computer Simulation , Cost-Benefit Analysis , Energy Intake , Female , Finland , Food Preferences , Humans , Logistic Models , Male , Middle Aged , Quality-Adjusted Life Years , Risk Factors
7.
Nutr Metab Cardiovasc Dis ; 21(9): 748-56, 2011 Sep.
Article En | MEDLINE | ID: mdl-20605427

BACKGROUND AND AIMS: Dietary fibre (DF) may play an important role in weight control. The amount, type and way of processing of DF modify food structure and subsequent postprandial appetitive, metabolic and hormonal effects, but current understanding about the magnitude of effects that specific types and amounts of DF exert are still poorly understood. METHODS AND RESULTS: We investigated the effects of wheat and oat brans alone and as combination in semisolid food matrix on postprandial appetite profile and gastrointestinal (GI) hormonal responses. Twenty healthy, normal-weight subjects (5 male/15 female, aged 23.3 ± 0.85y) participated in the study. Isoenergetic and isovolumic (1250 kJ, 300 g) puddings with different insoluble and soluble DF content were tested in a randomised order: pudding with 1) no added fibre, 2) 10 g wheat bran DF, 3) 10 g oat bran DF and 4) combination including 5 g wheat bran DF + 5 g oat bran DF. Blood samples were drawn before and 15, 30, 45, 60, 90, 120 and 180 min after the test meals to determine plasma glucose, ghrelin, peptide YY (PYY) and serum insulin concentrations. Subjective profiles of appetite were assessed using visual analogue scales (VAS). Plasma glucose (P = 0.001) and serum insulin (P < 0.001) responses were the lowest after the pudding with the greatest amount of ß-glucan. In contrast, postprandial ghrelin or PYY responses or appetite sensations did not differ among the meals. CONCLUSION: Oat ß-glucan decreased postprandial plasma glucose and serum insulin responses, yet had no significant effects on GI peptide responses or appetite ratings.


Avena/chemistry , Blood Glucose/drug effects , Insulin/blood , Adult , Appetite/drug effects , Cross-Over Studies , Dietary Fiber/administration & dosage , Energy Intake , Female , Gastrointestinal Tract/metabolism , Ghrelin/blood , Ghrelin/drug effects , Humans , Male , Peptide YY/blood , Peptide YY/drug effects , Postprandial Period/drug effects , Single-Blind Method , Triticum/chemistry , Young Adult
8.
Exp Clin Endocrinol Diabetes ; 118(10): 757-9, 2010 Nov.
Article En | MEDLINE | ID: mdl-20361391

Physical activity exerts anti-inflammatory effects, but genetic variation may modify its influence. In particular, the rs1800629 single-nucleotide polymorphism (SNP) in the tumor necrosis factor ( TNF) gene and the rs1800795 SNP in the interleukin-6 ( IL6) gene have been found to modify the effect of exercise training on circulating levels of C-reactive protein (CRP) and IL-6, respectively. We assessed whether rs1800629 and rs1800795 modified the effect of moderate-to-vigorous physical activity on changes in serum levels of high-sensitivity CRP and IL-6 in the Finnish Diabetes Prevention Study (DPS). Genotype and 1-year data on changes in physical activity, serum CRP and IL-6 were available for 390 overweight subjects with impaired glucose tolerance. The rs1800629 SNP in TNF interacted with the 1-year change in moderate-to-vigorous physical activity on changes in CRP among those who had high (≥3 mg/L) baseline CRP levels ( P = 0.034 for interaction). Carriers of the GG genotype showed a greater decrease in CRP with increasing physical activity than the individuals with the A allele. No interaction between the rs1800795 SNP in IL6 and changes in moderate-to-vigorous physical activity on the 1-year change in serum IL-6 was found. In conclusion, the rs1800629 SNP in the TNF gene may modify the effect of moderate-to-vigorous physical activity on serum levels of CRP.


C-Reactive Protein/analysis , Motor Activity/physiology , Overweight/blood , Overweight/therapy , Polymorphism, Single Nucleotide , Tumor Necrosis Factor-alpha/genetics , Diabetes Mellitus, Type 2/prevention & control , Female , Finland , Genetic Association Studies , Glucose Intolerance , Humans , Interleukin-6/genetics , Male , Promoter Regions, Genetic/genetics , Time Factors
9.
Int J Sports Med ; 31(2): 110-7, 2010 Feb.
Article En | MEDLINE | ID: mdl-20222003

We examined effects of 21 weeks of strength and/or endurance training and nutrition on serum hormones and physical fitness in 39-64-year-old women. Subjects (n=79) were randomized into the endurance group (E), strength group (S), combined group (SE) and controls (C). Total body strength training and high-intensity bicycle training were used. Average energy and nutrient intake remained the same in all groups. Body fat (dual energy X-ray absorptiometry) decreased significantly in all training groups and body mass index in E, SE and C. Only SE increased total body lean mass (2.2%, p=0.001), between groups p=0.044. Maximal cycling power increased more in E (16%) and SE (17%) than in S (8%)(all p<0.001), between groups p<0.001. Knee extension strength increased only in S (7%, p=0.006) and SE (11%, p<0.001). The changes in serum hormones did not differ between the groups, except insulin-like growth factor-1 (p=0.028), characterized by an 8% (p=0.097) increase in SE and a 7% (p=0.074) decrease in C. In women combined training led to marked improvements in physical fitness and body composition. Energy and protein intake was sufficient to ensure training-induced adaptations in muscle mass and physical fitness in response to both endurance and strength training, even though the energy balance was slightly negative in the endurance-trained groups.


Eating , Hormones/blood , Physical Endurance/physiology , Physical Fitness/physiology , Resistance Training , Adaptation, Physiological , Adult , Body Mass Index , Female , Humans , Insulin-Like Growth Factor I/analysis , Knee/physiology , Middle Aged
10.
Nutr Metab Cardiovasc Dis ; 20(4): 249-57, 2010 May.
Article En | MEDLINE | ID: mdl-19553094

BACKGROUND AND AIMS: Whole-grain cereals and diets with a low glycemic index may protect against the development of type 2 diabetes and heart disease, but the mechanisms are poorly understood. We studied the effect of carbohydrate modification on serum metabolic profiles, including lipids and branched chain amino acids, and dependencies between these and specific gene expression pathways in adipose tissue. METHODS AND RESULTS: Twenty subjects with metabolic syndrome were selected from the larger FUNGENUT study population, randomized either to a diet high in oat and wheat bread and potato (OWP) or rye bread and pasta (RP). Serum metabolomics analyses were performed using ultra-performance liquid chromatography coupled to electrospray ionization mass spectrometry (UPLC/MS), gas chromatography (GC) and UPLC. In the OWP group multiple proinflammatory lysophosphatidylcholines increased, while in the RP group docosahexaenoic acid (DHA 22:6n-3) increased and isoleucine decreased. mRNA expression of stress reactions- and adipose tissue differentiation-related genes were up-regulated in adipose tissue in the OWP group. In the RP group, however, pathways related to stress reactions and insulin signaling and energy metabolism were down-regulated. The lipid profiles had the strongest association with the changes in the adipose tissue differentiation pathway when using the elastic net regression model of the lipidomic profiles on selected pathways. CONCLUSION: Our results suggest that the dietary carbohydrate modification alters the serum metabolic profile, especially in lysoPC species, and may, thus, contribute to proinflammatory processes which in turn promote adverse changes in insulin and glucose metabolism.


Dietary Carbohydrates/pharmacology , Metabolic Syndrome/blood , Metabolic Syndrome/diet therapy , Adipose Tissue/metabolism , Adipose Tissue/physiology , Amino Acids, Branched-Chain/blood , Biosynthetic Pathways , Chromatography, High Pressure Liquid , Diet , Eating , Fatty Acids/blood , Gene Expression/drug effects , Gene Expression/genetics , Glycemic Index , Humans , Lipids/blood , Metabolic Syndrome/genetics , Metabolomics , Skinfold Thickness , Spectrometry, Mass, Electrospray Ionization , Treatment Outcome
11.
Scand J Med Sci Sports ; 20(1): 83-9, 2010 Feb.
Article En | MEDLINE | ID: mdl-19017295

In diabetes, defense systems against cellular stress are impaired. Heat shock proteins (HSPs) function primarily as molecular chaperones. Factors that raise tissue HSP levels may slow progression of diabetes and improve diabetic complications that also affect brain tissue. This study tested the effect of an 8-week exercise training on brain HSP response in rats with or without streptozotocin-induced diabetes (SID). In untrained animals, the HSP levels were not different between SID and non-diabetic groups. Endurance training, however, increased HSP72 and HSP90 protein in non-diabetic rats, whereas SID significantly decreased the effect of training on these HSPs. At the mRNA level, HSP60, HSP90 and GRP75 were increased due to training, whereas HSP72 mRNA was only increased in exercise-trained diabetic animals. Training or diabetes had no effect on protein carbonyl content, a marker of oxidative damage. Altogether, our findings suggest that endurance training increases HSP expression in the brain, and that experimental diabetes is associated with an incomplete HSP response at the protein level.


Brain/metabolism , Diabetes Mellitus, Experimental/metabolism , Oxidative Stress/physiology , Physical Conditioning, Animal/physiology , Animals , HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins , Male , Membrane Proteins/metabolism , Peptide Elongation Factor 1/metabolism , Peptide Elongation Factor 2/metabolism , Physical Endurance/physiology , Protein Carbonylation/physiology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Up-Regulation/physiology
12.
Scand J Med Sci Sports ; 19(6): 885-95, 2009 Dec.
Article En | MEDLINE | ID: mdl-19508653

This study compared 21 weeks of combined high-intensity strength and endurance training with endurance or strength training only on metabolic risk factors in 40-65-year-old men. The healthy men (n=63) were randomized into endurance (E), strength (S), combined strength and endurance training (SE) and control (C) groups. S and E trained two times a week and SE 2+2 times a week. Systolic (SBP) and diastolic blood pressure decreased significantly both in E (-6+/-8 and -4+/-6 mmHg) and in S (-9+/-8 and -5+/-7 mmHg), but not in SE or C (P=0.003 for the difference in the changes of SBP between the groups). The changes in serum glucose and insulin during an oral glucose tolerance test did not differ between the groups. Only E decreased serum fasting insulin levels (-17+/-27%, P=0.013). Minor changes were observed in blood lipids and lipoproteins in all groups. Both endurance and strength training can modestly improve metabolic health even in relatively lean older men with normal glucose tolerance. Combined strength and endurance training did not produce complementary benefits on metabolic risk factors. Combined training is effective in improving body composition and cardiorespiratory and muscular fitness, however, which is likely to decrease the risk of future metabolic and cardiovascular disease.


Energy Metabolism/physiology , Physical Endurance/physiology , Resistance Training , Adult , Aged , Anthropometry , Blood Pressure/physiology , Exercise Test , Finland , Glucose/analysis , Humans , Insulin/blood , Lipoproteins/blood , Male , Middle Aged , Oxygen Consumption/physiology , Risk Factors
13.
Res Vet Sci ; 87(3): 462-7, 2009 Dec.
Article En | MEDLINE | ID: mdl-19427659

Heat shock protein (HSP) expression is an adaptive mechanism against the disruption of cell homeostasis during exercise. Several antioxidant supplementation strategies have been used to enhance tissue protection. In this study, we examined the effects of a redox modulator, alpha-lipoic acid (LA) on HSP responses in six standardbred trotters following intense aerobic exercise. DL-LA supplementation (25 mg kg(-1) d(-1)) for five weeks increased the resting levels of HSP90 (1.02+/-0.155 in control and 1.26+/-0.090 after supplementation in arbitrary units) and the recovery levels of inducible HSP70 (0.89+/-0.056 in control and 1.05+/-0.089 after supplementation in arbitrary units) in skeletal muscle. Furthermore, LA increased skeletal muscle citrate synthase activity at rest and lowered the blood lactate concentration during exercise without any changes in the heart rate. LA had no effect on concentrations of HSP60, HSP25 or GRP75 in skeletal muscle. LA decreased the exercise-induced increases in plasma aspartate aminotransferase and creatine kinase concentrations during recovery. Our results suggest that LA supplementation may enhance tissue protection and increase oxidative capacity of the muscle in horse.


Heat-Shock Proteins/metabolism , Horses/physiology , Lactic Acid/blood , Physical Conditioning, Animal/adverse effects , Thioctic Acid/pharmacology , Animal Feed , Animals , Diet/veterinary , Dietary Supplements , Female , Male
14.
Nutr Metab Cardiovasc Dis ; 19(9): 626-33, 2009 Nov.
Article En | MEDLINE | ID: mdl-19278844

BACKGROUND AND AIMS: Adipose tissue is an active endocrine organ that secretes signaling molecules involved in the regulation of insulin sensitivity, food intake and inflammation. Apelin is a peptide secreted by adipose tissue that has been shown to modulate cardiovascular tone in animals. The aim of this study was to measure abdominal fat, blood pressure and circulating apelin, adiponectin, leptin, ghrelin, TNF-alpha and IL-6 levels in patients with the metabolic syndrome after a diet-induced weight loss. METHODS AND RESULTS: 35 obese individuals with the metabolic syndrome underwent an 8-week very-low-calorie diet (VLCD) and a 6-month weight maintenance period (WM) with 120mg orlistat or placebo administered 3 times daily. VLCD and WM (-15.1+/-1.0kg) decreased mean arterial pressure (MAP), insulin, leptin, triglycerides and visceral and subcutaneous adipose tissue. Moreover, adiponectin increased in response to the weight loss. However, the overall changes in plasma apelin, TNF-alpha and IL-6 were non-significant. A correlation between plasma apelin and TNF-alpha was observed at baseline (0.41, p<0.05), and the minor changes in plasma apelin levels were associated with changes in BMI during VLCD and MAP and TNF-alpha during VLCD and WM periods. CONCLUSION: Despite reductions in BMI, body adiposity, MAP and enhancement of glucose metabolism and adiponectin in response to weight loss, no significant changes in plasma apelin, TNF-alpha and IL-6 were observed. However, apelin significantly correlated with TNF-alpha and MAP. These results suggest that apelin may not be that strongly correlated with the fat mass as an adipokine like the more abundant adipokines adiponectin or leptin and it might be involved in the regulation of inflammation and cardiovascular tone.


Anti-Obesity Agents/administration & dosage , Intercellular Signaling Peptides and Proteins/blood , Interleukin-6/blood , Lactones/administration & dosage , Metabolic Syndrome , Obesity , Tumor Necrosis Factor-alpha/blood , Adiponectin/blood , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Apelin , Biomarkers/blood , Blood Glucose/metabolism , Body Mass Index , Combined Modality Therapy , Diet, Reducing , Female , Ghrelin/blood , Humans , Insulin/blood , Leptin/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diet therapy , Metabolic Syndrome/drug therapy , Middle Aged , Obesity/blood , Obesity/diet therapy , Obesity/drug therapy , Orlistat , Placebos , Weight Loss/drug effects , Weight Loss/physiology
15.
Diabetologia ; 51(11): 2060-7, 2008 Nov.
Article En | MEDLINE | ID: mdl-18758745

AIMS/HYPOTHESIS: The transcription factor nuclear factor-kappa-B (NFkappaB) is implicated in inflammatory responses, obesity and the metabolic syndrome, while immune cells appear to play a central role in mediating insulin resistance and can be used as a model to study inflammation and its relationship with insulin resistance. In peripheral blood mononuclear cells of overweight participants with the metabolic syndrome, we evaluated (1) the effect of diet-induced weight loss on the expression of genes involved in NFkappaB activation and (2) their association with insulin sensitivity. The genes studied were: TNF receptors TNFRSF1A and TNFRSF1B, and IL1R1, TLR4, TLR2, ICAM1, CCL5 and IKBKB. METHODS: We analysed data from 34 overweight participants with abnormal glucose metabolism and the metabolic syndrome, who were randomised to a weight-reduction (n = 24) or control group (n = 10) for 33 weeks. The mRNA expression was measured using real-time PCR. Measures of insulin and glucose homeostasis were assessed by IVGTT and OGTT. RESULTS: In general, the genes studied were downregulated after weight loss intervention. The changes in TLR4, TLR2, CCL5 and TNFRSF1A mRNA expression were associated with an increase in insulin sensitivity index independently of the change in waist circumference (p < 0.05). The change in IKBKB expression correlated with most of the changes in gene expression in the weight-reduction group. CONCLUSIONS/INTERPRETATION: These results suggest that proteins encoded by CCL5, TLR2 and TLR4, and TNFRSF1A might contribute to insulin-resistant states that characterise obesity and the metabolic syndrome. TRIAL REGISTRATION: ClinicalTrials.gov NCT 00621205.


Chemokine CCL5/genetics , Metabolic Syndrome/genetics , NF-kappa B/physiology , Obesity/genetics , Overweight/genetics , Receptors, Tumor Necrosis Factor, Type I/genetics , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/genetics , Adult , Aged , Body Mass Index , Down-Regulation , Glucose Intolerance , Humans , Metabolic Syndrome/physiopathology , Middle Aged , Randomized Controlled Trials as Topic , Weight Loss
16.
Eur J Endocrinol ; 158(3): 333-41, 2008 Mar.
Article En | MEDLINE | ID: mdl-18299466

OBJECTIVE: Serum amyloid A (SAA) is a novel link between increased adipose tissue mass and low-grade inflammation in obesity. Little is known about the factors regulating its serum concentration and mRNA levels. We investigated the association between SAA and leptin in obese and normal weight subjects and analyzed the effect of weight reduction on serum SAA concentration and gene expression in adipose tissue of the obese subjects. METHODS: Seventy-five obese subjects (60+/-7 years, body mass index (BMI) 32.9+/-2.8 kg/m(2), mean+/-s.d.) with impaired fasting plasma glucose or impaired glucose tolerance and other features of metabolic syndrome, and 11 normal weight control subjects (48+/-9 years, BMI 23.7+/-1.9 kg/m(2)) were studied at the baseline. Twenty-eight obese subjects underwent a 12-week intensive weight reduction program followed by 5 months of weight maintenance. Blood samples and abdominal s.c. adipose tissue biopsies were taken at the baseline and after the follow-up. Gene expression was studied using real-time quantitative PCR. RESULTS: The gene expressions in women and serum concentrations of leptin and SAA were interrelated independently of body fat mass in the obese subjects (r=0.54, P=0.001; r=0.24, P=0.039 respectively). In multiple linear regression analyses, leptin mRNA explained 38% of the variance in SAA mRNA (P=0.002) in the obese women. Weight loss of at least 5% increased SAA mRNA expression by 48 and 36% in men and women, but serum SAA concentrations did not change. CONCLUSIONS: The association between SAA and leptin suggests an interaction between these two adipokines, which may have implications in inflammatory processes related to obesity and the metabolic syndrome.


Adipose Tissue/metabolism , Inflammation/metabolism , Leptin/metabolism , Obesity/metabolism , Serum Amyloid A Protein/metabolism , Adipocytes/pathology , Adipocytes/physiology , Adipose Tissue/pathology , Aged , Body Weight , Female , Gene Expression/physiology , Glucose Intolerance/immunology , Glucose Intolerance/metabolism , Humans , Leptin/genetics , Male , Metabolic Syndrome/immunology , Metabolic Syndrome/metabolism , Middle Aged , Obesity/immunology , Obesity/pathology , RNA, Messenger/metabolism , Serum Amyloid A Protein/genetics , Weight Loss/physiology
17.
Int J Obes (Lond) ; 32(2): 292-303, 2008 Feb.
Article En | MEDLINE | ID: mdl-17848939

OBJECTIVE: Lifestyle and genetic factors interact in the development of obesity and the metabolic syndrome. The molecular mechanisms underlying the beneficial dietary modifications are, however, unclear. We aimed to examine the effect of the long-term moderate weight reduction on gene expression in adipose tissue (AT) and to identify genes and gene clusters responsive to treatment and thereby likely contributing to the development of the metabolic syndrome. DESIGN: Randomized controlled and individualized weight reduction intervention. SUBJECTS: Forty-six subjects with impaired fasting glycemia or impaired glucose tolerance and features of metabolic syndrome, aged 60+/-7 years were randomized either to a weight reduction (WR) (n=28) or a control (n=18) group lasting for 33 weeks. MEASUREMENTS: Oral and intravenous glucose tolerance tests and subcutaneous AT biopsies were performed before and after the intervention. Gene expression of AT was studied using microarray technology in subgroups of WR (with weight reduction > or =5%, n=9) and control group (n=10). The results were confirmed using quantitative PCR. RESULTS: In the WR group, glucose metabolism improved. Moreover, an inverse correlation between the change in S (I) and the change in body weight was found (r=-0.44, P=0.026). Downregulation of gene expression (P<0.01) involving gene ontology groups of extracellular matrix and cell death was seen. Such changes did not occur in the control group. The tenomodulin-gene was one of the most downregulated genes (-39+/-16%, P<0.0001). Moreover, its expression correlated with insulin sensitivity (r=-0.34, P=0.005) before the intervention and with body adiposity both before (r=0.42, P=0.007) and after (r=0.30, P=0.056) the intervention. CONCLUSION: Genes regulating the extracellular matrix and cell death showed a strong downregulation after long-term weight reduction. This likely reflects a new stable state at the molecular level in AT. Further studies are warranted to elucidate the mechanisms of these genetic factors.


Blood Glucose/metabolism , Extracellular Matrix/genetics , Insulin/metabolism , Metabolic Syndrome/genetics , Obesity/genetics , Weight Loss/genetics , Adult , Aged , Case-Control Studies , Cell Death/genetics , Female , Gene Expression Regulation , Glucose Tolerance Test , Humans , Male , Middle Aged , Obesity/diet therapy
19.
Physiol Genomics ; 31(2): 264-72, 2007 Oct 22.
Article En | MEDLINE | ID: mdl-17636114

Single nucleotide polymorphisms (SNPs) in two genes regulating insulin secretion, SLC2A2 (encoding GLUT2) and ABCC8 (encoding SUR1), were associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in the Finnish Diabetes Prevention Study (DPS). We determined whether physical activity (PA), assessed annually with a questionnaire, modified the association of SNPs in SLC2A2 and ABCC8 with the conversion to T2D in the combined intervention and control groups of the DPS. Finnish overweight subjects with IGT (N = 479) were followed for an average of 4.1 yr. The interaction of the SNPs with the change in PA on the conversion to T2D was assessed using Cox regression with adjustments for the other components of the intervention (dietary changes, weight reduction). The carriers of the common homozygous genotype of rs5393, rs5394, or rs5404 of SLC2A2 and rs3758947 of ABCC8 who were in the lower third of the change in moderate-to-vigorous PA during the follow-up had a 2.6- to 3.7-fold increased risk of developing T2D compared with the upper third, whereas the rare allele carriers seemed to be unresponsive to changes in moderate-to-vigorous PA (for the interaction of genotype with change in PA, P = 0.022-0.027 for the SNPs in SLC2A2, and P = 0.007 for rs3758947). We conclude that moderate-to-vigorous PA may modify the risk of developing T2D associated with genes regulating insulin secretion (SLC2A2, ABCC8) in persons with IGT.


ATP-Binding Cassette Transporters/genetics , Diabetes Mellitus, Type 2/prevention & control , Exercise Therapy , Glucose Intolerance/therapy , Glucose Transporter Type 2/genetics , Polymorphism, Single Nucleotide , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels/genetics , Receptors, Drug/genetics , ATP-Binding Cassette Transporters/physiology , Combined Modality Therapy , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/genetics , Disease Progression , Exons/genetics , Female , Finland/epidemiology , Genetic Predisposition to Disease , Glucose Intolerance/diet therapy , Glucose Intolerance/genetics , Glucose Transporter Type 2/physiology , Health Promotion , Humans , Insulin/metabolism , Insulin Secretion , Male , Middle Aged , Overweight , Potassium Channels/physiology , Potassium Channels, Inwardly Rectifying/physiology , Promoter Regions, Genetic/genetics , Receptors, Drug/physiology , Risk , Sulfonylurea Receptors , Weight Loss
20.
Diabetologia ; 47(8): 1403-10, 2004 Aug.
Article En | MEDLINE | ID: mdl-15309290

AIMS/HYPOTHESIS: Low-grade inflammation has been implicated in the development of Type 2 diabetes and cardiovascular disease, but its role in the pathogenesis of the metabolic syndrome is unclear. We investigated the association between C-reactive protein (CRP) levels and the development of the metabolic syndrome and diabetes in men. METHODS: Serum CRP concentrations and factors related to insulin resistance were determined in middle-aged Finnish men who participated in a population-based cohort study and were free of diabetes at baseline. RESULTS: At the 11-year follow-up, 143 of 680 men had developed the metabolic syndrome as defined by the National Cholesterol Education Program (NCEP) and 103 of 598 men had developed the metabolic syndrome as defined by the World Health Organization (WHO). Our analyses excluded men with the metabolic syndrome by the respective definition at baseline. In all, 78 of 762 men developed diabetes over the same period. Men with CRP concentrations > or =3 mg/l had a several-fold higher age-adjusted risk of developing the metabolic syndrome (NCEP definition: odds ratio [OR]=3.2, 95% CI 1.9-5.5; WHO definition: OR=3.4, 95% CI 2.0-6.1) or diabetes (OR=4.1, 95% CI 2.1-8.0) than men whose CRP levels were <1.0 mg/l. Even after further adjustment for potentially confounding lifestyle factors and factors related to insulin resistance, the risk of diabetes (OR=2.3, 95% CI 1.0-5.1) was still increased in men with CRP concentrations > or =3 mg/l, but the association with the metabolic syndrome was no longer significant. CONCLUSIONS/INTERPRETATION: Low-grade inflammation may increase the risk of the metabolic syndrome and diabetes in middle-aged men, but some of the risk is mediated through obesity and factors related to insulin resistance.


C-Reactive Protein/analysis , Diabetes Mellitus, Type 2/blood , Insulin Resistance/physiology , Metabolic Syndrome/blood , Biomarkers/blood , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/epidemiology , Finland , Follow-Up Studies , Humans , Inflammation , Male , Metabolic Syndrome/diagnosis , Metabolic Syndrome/epidemiology , Middle Aged , Time Factors
...